Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Operative Atrial Fibrillation after Surgical Aortic Valve Replacement and the influence of HMG-CoA reductase inhibitors
2021-002210-13Phase 4Active
- Sponsor
- University Hospital Odense
- Start
- Oct 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atorvastatin, rosuvastatin, fluvastatin, pravastatin, simvastatin and 2 more in Atrial fibrillation (AFib) and atrial flutter (AFL), sponsored by University Hospital Odense. Primary endpoint: Post-operative atrial fibrillation incidence. Started Oct 2021; status: active.
02
Drugs
atorvastatinrosuvastatinfluvastatinpravastatinsimvastatin
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on 2021-002210-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002210-13.